Literature DB >> 35112217

Clinical factors and conventional MRI may independently predict progression-free survival and overall survival in adult pilocytic astrocytomas.

Ilah Shin1, Yae Won Park2, Sung Soo Ahn3, Jinna Kim3, Jong Hee Chang4, Se Hoon Kim5, Seung-Koo Lee3.   

Abstract

PURPOSE: Pilocytic astrocytoma (PA) is rare in adults, and only limited knowledge on the clinical course and prognosis has been available. The combination of clinical information and comprehensive imaging parameters could be used for accurate prognostic stratification in adult PA patients. This study was conducted to predict the prognostic factors from clinical information and conventional magnetic resonance imaging (MRI) features in adult PAs.
METHODS: A total of 56 adult PA patients were enrolled in the institutional cohort. Clinical characteristics including age, sex, anaplastic PA, presence of neurofibromatosis type 1, Karnofsky performance status, extent of resection, and postoperative treatment were collected. MRI characteristics including major axis length, tumor location, presence of the typical 'cystic mass with enhancing mural nodule appearance', proportion of enhancing tumor, the proportion of edema, conspicuity of the nonenhancing margin, and presence of a cyst were evaluated. Univariable and multivariable Cox proportional hazard modeling were performed.
RESULTS: The 5-year progression-free survival (PFS) and overall survival (OS) rates were 83.9% and 91.l%, respectively. On univariable analysis, older age, larger proportion of edema, and poor definition of nonenhancing margin were predictors of shorter PFS and OS, respectively (all Ps < .05). On multivariable analysis, older age (hazard ratio [HR] = 1.04, P = .014; HR = 1.14, P = .030) and poor definition of nonenhancing margin (HR = 3.66, P = .027; HR = 24.30, P = .024) were independent variables for shorter PFS and OS, respectively.
CONCLUSION: Age and the margin of the nonenhancing part of the tumor may be useful biomarkers for predicting the outcome in adult PAs.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Magnetic resonance imaging; Overall survival; Pilocytic astrocytoma; Progression-free survival

Mesh:

Year:  2022        PMID: 35112217     DOI: 10.1007/s00234-021-02872-y

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.995


  1 in total

1.  Adult patients with supratentorial pilocytic astrocytoma: long-term follow-up of prospective multicenter clinical trial NCCTG-867251 (Alliance).

Authors:  Paul D Brown; S Keith Anderson; Xiomara W Carrero; Brian P O'Neill; Caterina Giannini; Eva Galanis; Sunjay A Shah; Ross A Abrams; Walter J Curran; Jan C Buckner; Edward G Shaw
Journal:  Neurooncol Pract       Date:  2015-08-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.